Processa Pharmaceuticals Gestione
Gestione criteri di controllo 3/4
Processa Pharmaceuticals' CEO is George Ng, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $714.03K, comprised of 22.3% salary and 77.7% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth $23.00K. The average tenure of the management team and the board of directors is 4.2 years and 4.7 years respectively.
Informazioni chiave
George Ng
Amministratore delegato
US$714.0k
Compenso totale
Percentuale dello stipendio del CEO | 22.3% |
Mandato del CEO | 1.3yrs |
Proprietà del CEO | 0.6% |
Durata media del management | 4.2yrs |
Durata media del Consiglio di amministrazione | 4.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully
Dec 12Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?
Oct 20Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73
Aug 12We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully
Jul 07We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate
Jan 20Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans
Aug 26Processa Pharmaceuticals (PCSA) Presents At LD Micro Invitations XI Virtual Conference - Slideshow
Jun 15What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?
Mar 15Processa Pharmaceuticals: Multiple Shots On Goal With Total TAM Of $8B - Worth A Look
Jan 29How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?
Jan 20Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$12m |
Jun 30 2024 | n/a | n/a | -US$10m |
Mar 31 2024 | n/a | n/a | -US$10m |
Dec 31 2023 | US$714k | US$159k | -US$11m |
Compensazione vs Mercato: George's total compensation ($USD714.03K) is about average for companies of similar size in the US market ($USD655.65K).
Compensazione vs guadagni: Insufficient data to compare George's compensation with company performance.
AMMINISTRATORE DELEGATO
George Ng (50 yo)
1.3yrs
Mandato
US$714,031
Compensazione
Mr. George K. Ng, Esq. JD serves as CEO of Processa Pharmaceuticals, Inc. since August 08, 2023 and serves as its Director since August 08, 2023 and served as its Director since August 08 2023 until 2024....
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Director | 1.3yrs | US$714.03k | 0.61% $ 23.0k | |
Co-Founder | 7.8yrs | US$186.64k | 2.82% $ 105.4k | |
Co-Founder and Chief Development & Regulatory Officer | no data | US$321.73k | 0.67% $ 25.2k | |
Co-Founder | 7.8yrs | US$1.04m | 0.89% $ 33.4k | |
Co-Founder | 7.1yrs | US$1.02m | 0.36% $ 13.6k | |
Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
Senior Vice President of Clinical Research | less than a year | Nessun dato | Nessun dato |
4.2yrs
Durata media
62yo
Età media
Gestione esperta: PCSA's management team is considered experienced (4.2 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Director | 1.3yrs | US$714.03k | 0.61% $ 23.0k | |
Co-Founder | 7.1yrs | US$186.64k | 2.82% $ 105.4k | |
Independent Director | 2.3yrs | US$83.00k | 0.022% $ 829.3 | |
Member of Medical & Scientific Advisory Board | 4.7yrs | Nessun dato | Nessun dato | |
Independent Chairman of Board | 7.3yrs | US$54.00k | 0.11% $ 4.3k | |
Member of Medical & Scientific Advisory Board | 4.7yrs | Nessun dato | Nessun dato | |
Member of Medical & Scientific Advisory Board | 2.1yrs | Nessun dato | Nessun dato | |
Independent Director | 2.3yrs | US$83.00k | 0.043% $ 1.6k | |
Independent Director | 4.8yrs | US$54.00k | 0.088% $ 3.3k |
4.7yrs
Durata media
61.5yo
Età media
Consiglio di amministrazione esperto: PCSA's board of directors are considered experienced (4.7 years average tenure).